69 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Thursday’s Close
PACB Pacific Biosciences of California, Inc. $5.14 $678.18M Uptrend
Article Searches
Genome Sequencing Roundup https://seekingalpha.com/article/4160573-genome-sequencing-roundup?source=feed_sector_healthcare Apr 02, 2018 -
Pacific Biosciences Unveils New Version of Sequel Software http://www.zacks.com/stock/news/294964/pacific-biosciences-unveils-new-version-of-sequel-software?cid=CS-ZC-FT-294964 Mar 08, 2018 - Pacific Biosciences (PACB) enhances performance and cost-effectiveness of the Sequel System.
Pacific Biosciences (PACB) Down 15.6% Since Earnings Report: Can It Rebound? http://www.zacks.com/stock/news/294392/pacific-biosciences-pacb-down-156-since-earnings-report-can-it-rebound?cid=CS-ZC-FT-294392 Mar 05, 2018 - Pacific Biosciences (PACB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Pacific Biosciences of California Inc (PACB) Files 10-K for the Fiscal Year Ended on December ... http://www.gurufocus.com/news/646475/pacific-biosciences-of-california-inc-pacb-files-10k-for-the-fiscal-year-ended-on-december-31-2017 Feb 26, 2018 - Pacific Biosciences of California Inc (PACB) Files 10-K for the Fiscal Year Ended on December 31, 2017, Stocks: PACB, release date:Feb 26, 2018
Are Options Traders Betting on a Big Move in Pacific Biosciences (PACB) Stock? http://www.zacks.com/stock/news/293114/are-options-traders-betting-on-a-big-move-in-pacific-biosciences-pacb-stock?cid=CS-ZC--293114 Feb 21, 2018 - Surging implied volatility makes Pacific Biosciences (PACB) stock lucrative to the option traders.
Your Daily Pharma Scoop: GW Pharmaceuticals Pullback, Seattle Genetics Announces Collaboration Agreement, Catalyst Reports Data https://seekingalpha.com/article/4145334-daily-pharma-scoop-gw-pharmaceuticals-pullback-seattle-genetics-announces-collaboration?source=feed_sector_healthcare Feb 10, 2018 - GW Pharmaceuticals looks attractive following recent pullback.Seattle Genetics has entered into a collaboration and license agreement with Pieris Pharmaceuticals.Catalyst Bioscience announced topline
Battered Back Below $3, PacBio's Shares Offer High-Risk Upside https://seekingalpha.com/article/4144213-battered-back-3-pacbios-shares-offer-high-risk-upside?source=feed_tag_editors_picks Feb 08, 2018 - PacBio shares have seen significant weakness as erratic system sales highlight the fact that the company has yet to break through and gain real traction in its markets.Growth in consumables is much mo
What's Behind Pacific Biosciences of California's Sinking Fourth-Quarter Sales https://www.fool.com/investing/2018/02/02/whats-behind-pacific-biosciences-of-californias-si.aspx?source=iedfolrf0000001 Feb 02, 2018 - The gene-sequencing company didn't have much good news from the fourth quarter, but better days could be ahead.
Pacific Biosciences (PACB) Q4 Loss Narrows, Consumables Up http://www.zacks.com/stock/news/291186/pacific-biosciences-pacb-q4-loss-narrows-consumables-up?cid=CS-ZC-FT-291186 Feb 02, 2018 - Pacific Biosciences' (PACB) consumable revenue platform proves a vital growth-driver in Q4. Sales momentum in China remains robust.
Pacific Biosciences of California's (PACB) CEO Michael Hunkapiller on Q4 2017 Results - Earnings Call Transcript https://seekingalpha.com/article/4142462-pacific-biosciences-californias-pacb-ceo-michael-hunkapiller-q4-2017-results-earnings-call?source=feed_sector_healthcare Feb 01, 2018 - Pacific Biosciences of California Inc. (NASDAQ:PACB) Q4 2017 Earnings Conference Call February 01, 2018 04:30 PM ET Executives Trevin Rard - Investor Relations Michael Hunkapiller - President and Chie

Pages: 1234567

<<<Page 3>